Canada Life Diabetes Step Therapy Exception (M6453)

Canada Life's diabetes step therapy program requires a plan member to have been reimbursed for a Step 1 drug before a Step 2 drug is covered. When a Step 1 drug is not an option, the prescriber uses this exception form to name the Step 2 drug requested, the Step 1 classes that cannot be tried and the contraindications, such as renal impairment with the latest creatinine clearance.

Who completes it

The plan member completes the plan member information and signs the consent; the prescribing physician completes the physician pages, including diagnosis, drugs, contraindications, signature and licence number.

Submitting and payment

How to submit it
Send all pages to Canada Life's Drug Claims Management by mail, fax or email; Canada Life notes email is not secure and suggests another channel for anyone concerned.
Who pays
Any cost of completing the form is the responsibility of the plan member or patient.

Good to know

  • If a Step 1 drug was tried but not paid for by Canada Life, submit a pharmacy printout showing the previous use.
  • Step 1 classes listed are alpha-glucosidase inhibitors, biguanides, DPP-4 inhibitors, meglitinides, SGLT-2 inhibitors, sulfonylureas and thiazolidinediones.
  • Contraindication options include cardiorespiratory insufficiency, a history of ketoacidosis, lactic or metabolic acidosis, bone fractures, drug interactions, and hepatic or renal impairment.
  • Canada Life may require the drug to be bought from a designated pharmacy, and a health case manager will contact the physician if that applies.

Get the official form

Download the current version from the source each time; forms change without notice.

Diabetes Step Therapy Drug Exception Form

Fill it with Vero

Upload the fillable PDF once and Vero Documents fills it from the visit note and the chart, ready for you to review and sign. Download, print, or email the finished form, with the patient’s consent.

How this list is checked

A form is listed only after its name and number were confirmed on the issuing agency’s or insurer’s own website, or in the form itself. Each entry links to that source. The list was last checked in October 2026. Forms change without notice, so download the current version from the official page before you fill it in.

Vero is not affiliated with, or endorsed by, the agencies and insurers listed here. Read our editorial policy.

Frequently asked questions

What is Canada Life's diabetes step therapy program?

It requires the plan member to have received reimbursement for a Step 1 antidiabetic drug before becoming eligible for a Step 2 drug. When a Step 1 drug is not an option, the prescriber can complete this exception form and submit it to Canada Life for consideration.

What if the patient already tried a Step 1 drug under another plan?

If a Step 1 drug was tried but coverage was not provided by Canada Life, the form asks for a pharmacy printout demonstrating the previous use. The note appears twice: in the plan member section and beside the physician's list of Step 1 drug classes.

Does the step therapy exception apply only to type 2 diabetes?

The physician section asks whether the patient has type 2 diabetes and, if not, to give the indication, so another indication can be described. The prescriber then names the Step 2 drug requested and checks the Step 1 classes that cannot be tried, with the contraindication for each.